MRI in Ovarian Tumors

• Sponsor: Assiut University (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05769205
• Collaborator: principle investigator (Other)
• Enrollment: 25
• Arm: 1
• Anticipated Duration (Months): 33.1

Study Details

Study Description

Brief Summary

Role of multi paramrtric MRI and MRI perfusion in indetermint ovarian lesions by using ORADS MRI

Condition or Disease	Intervention/Treatment	Phase
Ovarian Neoplasms	Device: MRI	N/A

Detailed Description

Aim of study the purpose of this study is to investigate the capabilities of multi parametric MRI including DCE perfusion and DWI to discriminate between benign and malignant ovarian masses .

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 25 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Intervention Model Description: females with ovarian massesfemales with ovarian masses
• Masking: None (Open Label)
• Primary Purpose: Diagnostic
• Official Title: Role of Multi Paramertic MRI and MRI Perfusion in Indetermint Ovarian Lesions by Using ORADS MRI
• Anticipated Study Start Date: Mar 1, 2023
• Anticipated Primary Completion Date: Mar 1, 2025
• Anticipated Study Completion Date: Dec 1, 2025

Arms and Interventions

Arm	Intervention/Treatment
Experimental: female with ovarian masses MRI with contrast according to the kidney function test of the patients	Device: MRI; MRI with contrast

Outcome Measures

Primary Outcome Measures

1. MRI in ovarian tumors [2 years]

   Role of parametric MRI in determint ovarian lesions by using ORADS MRI

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria: females with ovarian masses

-

Exclusion Criteria:

• females with known benign ovarian masses

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Assiut University
• principle investigator

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

• Patel RK, Garg A, Dixit R, Gandhi G, Khurana N. The role of "penumbra sign" and diffusion-weighted imaging in adnexal masses: do they provide a clue in differentiating tubo-ovarian abscess from ovarian malignancy? Pol J Radiol. 2021 Dec 15;86:e661-e671. doi: 10.5114/pjr.2021.111986. eCollection 2021.

• Responsible Party: Maryam Farouk Mahmoud Sayed, Assiut university, Assiut University
• ClinicalTrials.gov Identifier: NCT05769205
• Other Study ID Numbers: MRI in ovarian tumors
• First Posted: Mar 15, 2023
• Last Update Posted: Mar 15, 2023
• Last Verified: Feb 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Ovarian Neoplasms

Study Results

No Results Posted as of Mar 15, 2023